Advanced Cell Diagnostics rakes in $22 mln

Advanced Cell Diagnostics Inc, a developer of cell and tissue-based diagnostic tests for precision medicine, has secured $22 million in Series C funding. Summit Partners led the round with participation from Kenson Ventures, Morningside Ventures and New Leaf Venture Partners. In addition to the funding, Harrison Miller, a managing director at Summit Partners, has been added to ACD’s board of directors.

North AmericaUSBriefs